Veradigm | MDRX - Gross Profit On Sales


Veradigm reported $83.44M in Gross Profit on Sales for its fiscal quarter ending in September of 2022.





Gross Profit On Sales Change Date
Alcidion AUD 21.02M 5.65M Dec/2025
Ambu A/S DKK 947M 68M Dec/2025
Amplifon EUR 103.17M 44.14M Sep/2025
Cardinal Health USD 2.4B 78M Dec/2025
Centene USD 2.14B 796M Dec/2025
Charles River Laboratories USD 271.96M 39.43M Dec/2025
Cigna USD 56.45B 50.29B Sep/2025
Coloplast 4.74B 27M Dec/2025
Computer Programs Systems USD 35.62M 3.23M Dec/2025
Convatec Group USD 660.5M 348.95M Dec/2024
CVS Health USD 13.57B 239M Dec/2025
Diasorin EUR 181.08M 19.92M Sep/2025
Elevance Health USD 11.68B 889M Dec/2025
General Electric Aerospace USD 3.8B 118M Dec/2025
Gulf Medical Proj AED 46.22M 8.48M Mar/2025
Humana USD 4.82B 754M Jun/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Laboratory Of America USD 993.2M 31.9M Dec/2025
Maximus USD 318.67M 14.88M Dec/2025
McKesson USD 3.68B 143M Dec/2025
Med Life RON 628.26M 7.99M Sep/2025
Molina Healthcare USD 1.2B 193M Dec/2025
Omnicell USD 130.32M 4.18M Dec/2025
Oriola-kd EUR 40.2M 2.1M Sep/2025
Owens Minor USD 272.05M 20.92M Dec/2025
Quest Diagnostics USD 873M 37M Dec/2025
Rede D'or Sao Luiz BRL 3.18B 176.73M Dec/2025
Siemens Healthineers EUR 2.08B 299M Dec/2025
Sonova Holding CHF 1.28B 205.2M Dec/2025
Supermax Corporation Bhd MYR -143.15M 161.11M Sep/2025
UnitedHealth USD 20.64B 77.96B Sep/2025
Veeva Systems USD 622.47M 7.11M Dec/2025
Veradigm USD 83.44M 3.95M Sep/2022
Xerox USD 441M 15M Jun/2025